Developer docs
API playgroundTry for free, no card

Search company profiles

Biobase

Full company profile

uuid00dzppi

Namestring
Biobase
Legal namestring
Biobase, Inc.
Websiteurl
biobase.ai
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Biobase is a privately held healthcare data infrastructure company headquartered in San Diego, California, incorporated in Delaware and founded in 2025. The company provides a federated operating system for multimodal clinical data that connects healthcare data suppliers (labs, hospitals, and health systems) with research buyers (pharma, biotech, AI companies, and CROs). Its platform enables compliant, privacy-preserving data exchange without raw data movement and consists of seven integrated modules: the core Agentic Operating System, Natural Language Querying, Federated Architecture, Built-In HIPAA Compliance, Multi-Modal Integration (pathology, molecular, genomic, and outcomes), Agentic Workflows for automated procurement, and Clinical Trial Matching.

The technology stack centers on an AI-native agentic architecture where AI agents automate cohort building, analytics, workflow orchestration, and procurement—compressing procurement cycles from months to minutes per company claims. The platform supports natural language querying across multimodal datasets, federated compute for privacy preservation, and built-in de-identification and consent management. Biobase serves two primary vertical segments: Healthcare and Lab Partners seeking to monetize clinical data assets, and Life Sciences and Biotech buyers seeking instant access to multimodal datasets for drug discovery, clinical trials, and AI development.

Biobase generates revenue through multiple streams including marketplace commissions on data transactions, transaction fees for data asset commercialization services, and subscription-based AI-powered internal tools for healthcare institutions. The go-to-market combines enterprise field sales (Request a Demo CTAs targeting healthcare systems and life sciences buyers) with product-led growth through self-serve natural language exploration. Pricing is quote-based and not publicly disclosed. The team of approximately six includes five co-founders with prior experience at Paige, Pictor Labs, Danaher, OTTO, Grasshopper, Augmedix, Arterys, Elephas, Walgreens, PwC, IBEX, Olympus, and Philips Healthcare, plus a Head of AI and a Data Engineering lead.

Short descriptiontext

Biobase is a healthcare data infrastructure company providing a federated, AI-native operating system for multimodal clinical data, connecting healthcare providers and life sciences organizations through privacy-preserving compute and agentic workflow automation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical data infrastructure, federated data platform, healthcare data monetization, agentic AI workflows, multimodal data integration
Industry3 codes
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers5132
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Healthcare Data Infrastructure
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Data Monetization Platform Fees
TypeMarketplace Commission
Description

Platform facilitates connections between healthcare data suppliers and life sciences buyers, earning fees for enabling compliant data transactions.

biobase.ai
2Data Asset Commercialization Services
TypeTransaction Fee
Description

Helps labs, hospitals, and health systems monetize clinical data assets (pathology, molecular, outcomes) into revenue streams while handling compliance and de-identification.

biobase.ai
3AI-Powered Internal Tools
TypeSubscription Recurring
Description

Natural language querying and analytics tools for internal workflows at healthcare institutions.

biobase.ai
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Biobase provides "The Agentic Operating System for Clinical Data," a federated software platform that enables compliant, privacy-preserving connections between healthcare data suppliers (labs, hospitals, health systems) and life sciences buyers (pharma, biotech, AI companies, CROs). The platform unifies multimodal clinical data (pathology, molecular, genomic, outcomes), automates cohort building, dataset discovery, feasibility analysis, clinical trial matching, and contracting through AI agents, and embeds HIPAA-grade compliance, consent management, and de-identification as core infrastructure. It delivers internal natural-language-query analytics tools to healthcare institutions and a compliant data-commercialization channel on the buyer side.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Procurement cycles compressed from months to minutes
+1 more record
Product overview1 text field

Biobase offers a unified Health Data Operating System called 'The Agentic Operating System for Clinical Data'—a federated platform for multimodal clinical data that enables compliant, privacy-preserving connections between healthcare systems and research buyers. The platform consists of seven integrated modules: the core Agentic Operating System paired with Natural Language Querying for text-based data exploration, Federated Architecture for privacy-preserving data access without raw data movement, Built-In Compliance for HIPAA and regulatory requirements, Multi-Modal Integration for pathology/molecular/genomics/outcomes data unification, Agentic Workflows for automated procurement and contracting, and Clinical Trial Matching for patient-site optimization. This architecture provides healthcare and life science organizations with an end-to-end solution for clinical data monetization, discovery, and AI-powered analytics.

Product and service1 record
1The Agentic Operating System for Clinical Data
CategoryHealthcare Data Infrastructure Software Platform
Description

Biobase's flagship platform that serves as a federated operating system for multimodal clinical data. It enables compliant, privacy-preserving connections between healthcare systems and research buyers, providing the infrastructure layer for clinical data liquidity that powers precision medicine. Delivered to healthcare and lab partners (data suppliers) and life sciences buyers (pharma, biotech, AI companies, CROs).

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1HealthVerity
TypeDirect peer
Description

HealthVerity provides a privacy-protected data exchange for clinical and consumer health data used by life sciences and government clients. It competes directly with Biobase in enabling compliant data transactions.

TypeEmerging player
Description

Seqster offers a patient-centric interoperability platform that consolidates EHR, genomic, and wearables data. Its multi-modal integration and consent-driven sharing approach overlaps with Biobase's federated, consent-aware architecture.

TypeDirect peer
Description

Truveta is a health-system-owned data platform pooling EHR records for research and life sciences use. Like Biobase, it positions itself as a regulated, consent-aware channel between providers and biopharma buyers.

TypeDirect peer
Description

Datavant operates a health data connectivity and de-identification platform that links patient-level data across providers and life sciences buyers. It is the most direct competitor to Biobase's data liquidity and marketplace model.

TypeBroad incumbent
Description

AWS HealthLake is a managed cloud service for storing, querying, and analyzing clinical data at scale. It competes with Biobase as a horizontal infrastructure layer that health systems could use for similar data liquidity workflows.

6Tempus AI
TypeDirect peer
Description

Tempus builds a multi-modal clinical data platform combining molecular, pathology, and outcomes data to serve both providers and biopharma. Its data licensing and AI-ready dataset offerings directly overlap with Biobase's supplier and buyer use cases.

TypeDirect peer
Description

Flatiron aggregates oncology real-world data from academic and community health systems and licenses it to life sciences clients. Its data sourcing from EHRs and clinical workflows is structurally similar to Biobase's hospital data commercialization model.

TypeBroad incumbent
Description

Verily operates broad real-world data and clinical evidence platforms as part of Alphabet's health portfolio. It overlaps with Biobase in delivering longitudinal, multi-modal clinical datasets to life sciences and research customers.

TypeEmerging player
Description

Atropos Health runs real-world evidence queries on top of federated clinical data for providers and life sciences customers. It competes with Biobase in serving biopharma with rapid, compliant access to clinical datasets.

TypeBroad incumbent
Description

Palantir's Foundry platform is widely used by large health systems and life sciences companies to integrate and analyze multimodal clinical and operational data. It is an incumbent infrastructure option that overlaps with Biobase's positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biobase

Healthcare Data Infrastructurebiobase.ai

Biobase is a healthcare data infrastructure company providing a federated, AI-native operating system for multimodal clinical data, connecting healthcare providers and life sciences organizations through privacy-preserving compute and agentic workflow automation.

What Biobase does

Biobase is a privately held healthcare data infrastructure company headquartered in San Diego, California, incorporated in Delaware and founded in 2025. The company provides a federated operating system for multimodal clinical data that connects healthcare data suppliers (labs, hospitals, and health systems) with research buyers (pharma, biotech, AI companies, and CROs). Its platform enables compliant, privacy-preserving data exchange without raw data movement and consists of seven integrated modules: the core Agentic Operating System, Natural Language Querying, Federated Architecture, Built-In HIPAA Compliance, Multi-Modal Integration (pathology, molecular, genomic, and outcomes), Agentic Workflows for automated procurement, and Clinical Trial Matching.

The technology stack centers on an AI-native agentic architecture where AI agents automate cohort building, analytics, workflow orchestration, and procurement—compressing procurement cycles from months to minutes per company claims. The platform supports natural language querying across multimodal datasets, federated compute for privacy preservation, and built-in de-identification and consent management. Biobase serves two primary vertical segments: Healthcare and Lab Partners seeking to monetize clinical data assets, and Life Sciences and Biotech buyers seeking instant access to multimodal datasets for drug discovery, clinical trials, and AI development.

Biobase generates revenue through multiple streams including marketplace commissions on data transactions, transaction fees for data asset commercialization services, and subscription-based AI-powered internal tools for healthcare institutions. The go-to-market combines enterprise field sales (Request a Demo CTAs targeting healthcare systems and life sciences buyers) with product-led growth through self-serve natural language exploration. Pricing is quote-based and not publicly disclosed. The team of approximately six includes five co-founders with prior experience at Paige, Pictor Labs, Danaher, OTTO, Grasshopper, Augmedix, Arterys, Elephas, Walgreens, PwC, IBEX, Olympus, and Philips Healthcare, plus a Head of AI and a Data Engineering lead.

Biobase firmographics

Firmographics
Name
Biobase
Legal name
Biobase, Inc.
Website
https://biobase.ai
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
11–50 employees
Short description
Biobase is a healthcare data infrastructure company providing a federated, AI-native operating system for multimodal clinical data, connecting healthcare providers and life sciences organizations through privacy-preserving compute and agentic workflow automation.
Ownership category
akta.pro rank

Biobase industry classification

Industry
Product category
Healthcare Data Infrastructure
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Clinical data infrastructure
  • Federated data platform
  • Healthcare data monetization
  • Agentic AI workflows
  • Multimodal data integration

Where Biobase is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Biobase business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Data Monetization Platform Fees: Platform facilitates connections between healthcare data suppliers and life sciences buyers, earning fees for enabling compliant data transactions.
  2. Data Asset Commercialization Services: Helps labs, hospitals, and health systems monetize clinical data assets (pathology, molecular, outcomes) into revenue streams while handling compliance and de-identification.
  3. AI-Powered Internal Tools: Natural language querying and analytics tools for internal workflows at healthcare institutions.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Biobase product offering

Product offering

Core offering

Biobase provides "The Agentic Operating System for Clinical Data," a federated software platform that enables compliant, privacy-preserving connections between healthcare data suppliers (labs, hospitals, health systems) and life sciences buyers (pharma, biotech, AI companies, CROs). The platform unifies multimodal clinical data (pathology, molecular, genomic, outcomes), automates cohort building, dataset discovery, feasibility analysis, clinical trial matching, and contracting through AI agents, and embeds HIPAA-grade compliance, consent management, and de-identification as core infrastructure. It delivers internal natural-language-query analytics tools to healthcare institutions and a compliant data-commercialization channel on the buyer side.

Product overview

Biobase offers a unified Health Data Operating System called 'The Agentic Operating System for Clinical Data'—a federated platform for multimodal clinical data that enables compliant, privacy-preserving connections between healthcare systems and research buyers. The platform consists of seven integrated modules: the core Agentic Operating System paired with Natural Language Querying for text-based data exploration, Federated Architecture for privacy-preserving data access without raw data movement, Built-In Compliance for HIPAA and regulatory requirements, Multi-Modal Integration for pathology/molecular/genomics/outcomes data unification, Agentic Workflows for automated procurement and contracting, and Clinical Trial Matching for patient-site optimization. This architecture provides healthcare and life science organizations with an end-to-end solution for clinical data monetization, discovery, and AI-powered analytics.

Differentiator

Problem solved

Functional benefit

Products and services

  • The Agentic Operating System for Clinical Data Biobase's flagship platform that serves as a federated operating system for multimodal clinical data. It enables compliant, privacy-preserving connections between healthcare systems and research buyers, providing the infrastructure layer for clinical data liquidity that powers precision medicine. Delivered to healthcare and lab partners (data suppliers) and life sciences buyers (pharma, biotech, AI companies, CROs).

Quantifiable outcome

  • Procurement cycles compressed from months to minutes
  • +1 more outcomes

Companies that use Biobase

Customer profile

Segments2 records

Ideal customer profiles2 records

Biobase technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Biobase partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights6 records

Biobase competitors and assessment

Company assessment

Direct peers

  • HealthVerity: HealthVerity provides a privacy-protected data exchange for clinical and consumer health data used by life sciences and government clients. It competes directly with Biobase in enabling compliant data transactions.
  • Truveta: Truveta is a health-system-owned data platform pooling EHR records for research and life sciences use. Like Biobase, it positions itself as a regulated, consent-aware channel between providers and biopharma buyers.
  • Datavant: Datavant operates a health data connectivity and de-identification platform that links patient-level data across providers and life sciences buyers. It is the most direct competitor to Biobase's data liquidity and marketplace model.
  • Tempus AI: Tempus builds a multi-modal clinical data platform combining molecular, pathology, and outcomes data to serve both providers and biopharma. Its data licensing and AI-ready dataset offerings directly overlap with Biobase's supplier and buyer use cases.
  • Flatiron Health: Flatiron aggregates oncology real-world data from academic and community health systems and licenses it to life sciences clients. Its data sourcing from EHRs and clinical workflows is structurally similar to Biobase's hospital data commercialization model.

Emerging players

  • Seqster: Seqster offers a patient-centric interoperability platform that consolidates EHR, genomic, and wearables data. Its multi-modal integration and consent-driven sharing approach overlaps with Biobase's federated, consent-aware architecture.
  • Atropos Health: Atropos Health runs real-world evidence queries on top of federated clinical data for providers and life sciences customers. It competes with Biobase in serving biopharma with rapid, compliant access to clinical datasets.

Broad incumbents

  • AWS HealthLake: AWS HealthLake is a managed cloud service for storing, querying, and analyzing clinical data at scale. It competes with Biobase as a horizontal infrastructure layer that health systems could use for similar data liquidity workflows.
  • Verily (Alphabet): Verily operates broad real-world data and clinical evidence platforms as part of Alphabet's health portfolio. It overlaps with Biobase in delivering longitudinal, multi-modal clinical datasets to life sciences and research customers.
  • Palantir Foundry: Palantir's Foundry platform is widely used by large health systems and life sciences companies to integrate and analyze multimodal clinical and operational data. It is an incumbent infrastructure option that overlaps with Biobase's positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Biobase social profiles

Digital presence

Biobase compliance and trust

Trust signal

Compliance2 records

Biobase financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biobase leadership team

Management profile

Number of profiles

Profiles7 records

Biobase funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biobase M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobase

What does Biobase do?

Biobase provides "The Agentic Operating System for Clinical Data," a federated software platform that enables compliant, privacy-preserving connections between healthcare data suppliers (labs, hospitals, health systems) and life sciences buyers (pharma, biotech, AI companies, CROs). The platform unifies multimodal clinical data (pathology, molecular, genomic, outcomes), automates cohort building, dataset discovery, feasibility analysis, clinical trial matching, and contracting through AI agents, and embeds HIPAA-grade compliance, consent management, and de-identification as core infrastructure. It delivers internal natural-language-query analytics tools to healthcare institutions and a compliant data-commercialization channel on the buyer side.

Is Biobase a public or private company?

Biobase is a private company. It is classified as venture growth investor backed and is currently operating.

When was Biobase founded?

Biobase was founded in 2025. It employs 11 to 50 people.

Where is Biobase based?

Biobase is headquartered in San Diego, United States, in the North America region.

How does Biobase make money?

Three revenue lines are on record. Data Monetization Platform Fees are the primary driver. The others are data Asset Commercialization Services and AI-Powered Internal Tools.

Who are Biobase's main competitors?

Direct peers on record are HealthVerity, Truveta, Datavant, Tempus AI and Flatiron Health. Emerging players are Seqster and Atropos Health. Broad incumbents are AWS HealthLake, Verily (Alphabet) and Palantir Foundry.

Does Biobase have an API?

No public API is recorded for Biobase.

What industry is Biobase in?

Biobase's product category is Healthcare Data Infrastructure. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Empresas de Capital Riesgo en EspaBiobase Closes Pre-Seed Funding Round Backed by Nina Capital, DigiTx Partners and Washington Research FoundationBiobase has closed its pre-seed funding round backed by Nina Capital, DigiTx Partners, and Washington Research Foundation to accelerate the development of its AI-powered clinical data platform. The company plans to use the investment to expand its technology infrastructure and strengthen strategic partnerships within the healthcare and life sciences sectors.EIN PresswireBiobase and Techcyte partner to advance digital pathology and unlock the full potential of clinical dataTechcyte and Biobase announced a partnership to connect their digital pathology and data discovery platforms, enabling labs to commercialize de-identified clinical data. The integration allows agentic search for digital and physical samples, with labs retaining control and selective participation. The collaboration aims to offset digital transformation costs and expand data value.PRLogBiobase Announces Strategic Investment from BJC Health to Advance AI-Powered Healthcare Data OSBiobase, a healthcare data infrastructure company based in San Diego, announced receiving a strategic investment from BJC Health on January 22, 2026 to advance its AI-powered agentic operating system for clinical data. The investment validates Biobase's technology platform and establishes BJC Health as a flagship deployment site and center of excellence for responsible healthcare AI deployment. Both companies indicated the partnership will accelerate AI adoption across BJC's academic health system while demonstrating Biobase's capabilities in a real-world clinical environment at scale.Crunchbase NewsVoice Technology Booms Throughout Pandemic: Where Does It Go From Here?Voice technology has expanded significantly during the pandemic, with researchers developing apps to detect COVID-19 through voice patterns and clinicians using AI for administrative tasks. Mental health platforms like Wysa and BioBase are leveraging voice AI to address rising anxiety and depression rates by identifying emotional distress and providing cognitive behavioral therapy. Looking ahead, the integration of voice assistants into home automation, medical robotics, and security systems is expected to continue growing as a hands-free interface for daily life and professional use.